UVA1 rays (340–400 nm) contribute to carcinogenesis, immunosuppression, hyperpigmentation, and aging. Current sunscreen formulas lack sufficient absorption in the 370–400 nm wavelengths range. Recently, a new UVA1 filter, Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (MCE) exhibiting a peak of absorption at 385 nm, was approved by the Scientific Committee on Consumer Safety for use in sunscreen products. These studies evaluated, in a three-dimensional skin model and in vivo, the protection afforded by state-of-the-art sunscreen formulations enriched with MCE. This study is a monocentric, double-blinded, randomized, and comparative trial. This study is registered at ClinicalTrials.gov with the identification number NCT04865094. The efficacy of sunscreens with MCE was compared with that of reference formulas. In a three-dimensional skin model, histology, protein, and gene expression were analyzed. In the clinical trial, pigmentation was analyzed in 19 volunteers using colorimetric measurements and visual scoring. MCE addition in reference formulas enlarged the profile of absorption up to 400 nm; reduced UVA1-induced dermal and epidermal alterations at cellular, biochemical, and molecular levels; and decreased UVA1-induced pigmentation. Addition of MCE absorber in sunscreen formulations leads to full coverage of UV spectrum and improved UVA1 photoprotection. The data support benefits in the long term on sun-induced consequences, especially those related to public health care issues.
19 February 2024 in Journal of Cosmetic Dermatology
Background: Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2‐MNG to melanin precursors. Objective: To evaluate 2‐MNG in preventing both mechanisms in vivo. Methods: In a randomized, intra‐individual and controlled study, 33 subjects with melanin‐rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2‐MNG alone or 0.5% 2‐MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl‐SX (MSX, 1.5%). The respective vehicles were used as controls and 4‐n‐butyl‐resorcinol (4‐n‐BR, 2.5%) as a positive reference. Results: 2‐MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2‐MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2‐MNG 0.5% alone. 2‐MNG at 0.5% and 1% showed significantly better performance than 4‐n‐BR. Conclusions: 2‐MNG inhibited both UV‐induced skin pigmentation mechanisms in vivo. The association of 2‐MNG with LHA plus MSX showed the highest efficacy on melanin‐rich skin with pigmentation induced by UV exposure.
26 January 2023 in Journal of Cosmetic Dermatology
Background: Chronic sun exposure induces skin damage leading to skin ageing and skin colour heterogeneity with hyperpigmented spots. In this process ultra violet A (UVA) rays highly contribute, especially long‐UVA (UVA1) supporting the need for an efficient photoprotection over the whole UV spectrum. A new UVA1 filter, methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (MCE), with a pic of absorption at 385 nm, has been recently approved for use in sunscreen products.Objective: Three randomised clinical studies were performed to evaluate the additional photoprotection afforded by a sunscreen formula containing MCE compared to state‐of‐the‐art sunscreen lacking absorption in the longest UVA1 wavelengths. Two studies were performed on European volunteers with UV‐controlled (UVA1, ultra violet B (UVB) + UVA) exposures and one on Indian volunteers under real sun exposures.Methods: Three intraindividual trials (two randomised UV‐controlled and one real sun) were conducted on a total of 62 healthy subjects with Fitzpatrick III–IV and individual typology angle (ITA°) values between −18° and 35°. The MCE at 2% was formulated in a state‐of‐the‐art sun protection factor 30 sunscreen reference allowing to enlarge the absorption profile up to 400 nm. UV‐induced pigmentation was assessed by colorimetric measures and visual scoring at different time points after a single exposure to UVA1 (Study 1) or repeated exposures to daily UV radiation comprising both UVB and UVA (Study 2) or under real sun (Study 3).Results: Whatever the study exposure condition (UVA1, UVB + UVA, real sun), the level of pigmentation was increased as attested by colorimetric parameters (decreased luminance L* and ITA° values) and visual scorings. In the three studies, the comparison showed higher prevention of hyperpigmentation with the sunscreen enlarged in the longest UVA1 wavelengths with MCE compared to the state‐of‐the‐art sunscreen. No side effects were reported.Conclusions: MCE is a valuable UVA1 filter to improve photoprotection over the entire UV spectrum in state‐of‐the‐art sunscreens and limits the impact of UVA1 rays.